Patents by Inventor Benjamin Horenstein

Benjamin Horenstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of glycosyltransferase enzymes
    Publication number: 20020111496
    Abstract: The subject invention provides compounds and methods of producing compounds, which are useful inhibitors of glycosyltransferase enzymes. These compounds represent a new class of glycosyltransferase inhibitors and are potent inhibitors of sialyltransferase. The subject invention also provides methods of treating diseases or conditions associated with glycosytransferases. Methods of modulating the activity of glycosytransferases are also provided.
    Type: Application
    Filed: February 4, 2002
    Publication date: August 15, 2002
    Inventors: Benjamin A. Horenstein, Hongbin Sun
  • Transition-state inhibitors for nucleoside hydrolase and transferase reactions
    Patent number: 6121296
    Abstract: This invention is directed to transition-state analog compounds and to the use of said compounds as inhibitors of nucleoside hydrolase and transferase enzyme activity of parasites. This invention is further directed to the use of said compounds to treat infections and diseases caused by certain bacterial and plant toxins.
    Type: Grant
    Filed: February 2, 1998
    Date of Patent: September 19, 2000
    Assignee: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Vern L. Schramm, Benjamin Horenstein
  • Enzyme inhibitors and methods of use
    Patent number: 6020344
    Abstract: Novel enzyme-inhibitory compounds are disclosed. The subject invention further pertains to methods and compositions for the inhibition of bacteria, viruses, parasites, and other pathogens.
    Type: Grant
    Filed: July 31, 1998
    Date of Patent: February 1, 2000
    Assignee: University of Florida
    Inventors: Benjamin A. Horenstein, Ian B. Parr